Alendronate Sodium

CAS 121268-17-5 8 FDA-DMF suppliersSmall Molecule

Overview

Alendronate Sodium is a bisphosphonate used to prevent and treat osteoporosis in postmenopausal women and in men. It works by inhibiting osteoclast-mediated bone resorption, thus strengthening bone structure.

API suppliers (5)

Suppliers of Alendronate Sodium backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • MINSHENG GROUP SHAOXING PHARMACEUTICAL CO LTD1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • ALCHYMARS SPA
  • MEDICHEM SASpain

Therapeutic areas

OsteoporosisBone Density Conservation Agents

Related APIs

Zoledronic Acid
25 suppliers
Teriparatide
14 suppliers
Raloxifene Hydrochloride
11 suppliers
Risedronate Sodium
7 suppliers
Etidronate Disodium
6 suppliers
Ibandronate Sodium
5 suppliers
Bazedoxifene Acetate
5 suppliers
Pamidronate Disodium
4 suppliers

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.

Start free trialBook a demo